N-(3-(4-(imidazo[1,2-b]pyridazin-3-yl)-1H-pyrazol-1-yl)-4-methylphenyl)-4-(morpholinomethyl)benzamide

ID: ALA4780376

PubChem CID: 162663597

Max Phase: Preclinical

Molecular Formula: C28H27N7O2

Molecular Weight: 493.57

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=O)c2ccc(CN3CCOCC3)cc2)cc1-n1cc(-c2cnc3cccnn23)cn1

Standard InChI:  InChI=1S/C28H27N7O2/c1-20-4-9-24(32-28(36)22-7-5-21(6-8-22)18-33-11-13-37-14-12-33)15-25(20)34-19-23(16-31-34)26-17-29-27-3-2-10-30-35(26)27/h2-10,15-17,19H,11-14,18H2,1H3,(H,32,36)

Standard InChI Key:  VITWTRRNFRBXSR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 37 42  0  0  0  0  0  0  0  0999 V2000
   19.7969   -2.7281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7958   -3.5476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5038   -3.9566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2135   -3.5471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2106   -2.7245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5020   -2.3192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0891   -2.3196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9218   -3.9546    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.6289   -3.5449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3372   -3.9524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6276   -2.7277    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.3339   -4.7680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0414   -5.1754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7494   -4.7657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7455   -3.9443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0374   -3.5405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0877   -3.9556    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.3460   -3.6218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7987   -4.2287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2068   -4.9368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0062   -4.7674    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.9794   -4.2222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4968   -3.5545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7156   -3.8015    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.4863   -4.8800    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7105   -4.6250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1051   -5.1663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2698   -5.9655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0456   -6.2206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6567   -5.6764    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.4583   -5.1722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4607   -5.9894    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.7510   -6.3946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7514   -7.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4584   -7.6186    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.1668   -7.2092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1680   -6.3894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  4  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 10 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 10  1  0
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 17  1  0
 19 22  1  0
 22 23  2  0
 23 24  1  0
 24 26  2  0
 25 22  1  0
 25 26  1  0
 25 30  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 14 31  1  0
 31 32  1  0
 32 33  1  0
 32 37  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4780376

    ---

Associated Targets(Human)

ABL1 Tclin Bcr/Abl fusion protein (1667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK-293T (167025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 493.57Molecular Weight (Monoisotopic): 493.2226AlogP: 3.97#Rotatable Bonds: 6
Polar Surface Area: 89.58Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.60CX LogP: 3.63CX LogD: 3.57
Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.39Np Likeness Score: -2.18

References

1. Hu L,Cao T,Lv Y,Ding Y,Yang L,Zhang Q,Guo M.  (2016)  Design, synthesis, and biological activity of 4-(imidazo[1,2-b]pyridazin-3-yl)-1H-pyrazol-1-yl-phenylbenzamide derivatives as BCR-ABL kinase inhibitors.,  26  (23.0): [PMID:28029512] [10.1016/j.bmcl.2016.10.007]

Source